CVS Health sees FY19 adjusted EPS $6.68-$6.88, consensus $7.41
The company said it expects to continue to generate strong cash flows in 2019, with projected cash flow from operations between $9.8B-$10.3B. President and Chief Executive Officer Larry Merlo stated, "2019 will be a year of transition as we integrate Aetna and focus on key pillars of our growth strategy. We are fully aware of the need to address the impact of certain headwinds that are having a disproportionate impact in 2019 compared to prior years, and importantly, we are taking comprehensive actions to move past them. We understand acutely the importance of balancing near-term execution with longer-term vision, and we are confident that our actions will position us well in 2020 and beyond."